首页 | 官方网站   微博 | 高级检索  
     

参附注射液对戊巴比妥钠致心衰模型心肌细胞膜ATP酶和相关离子的影响
引用本文:徐菲飞,彭成,王茁伉,谢晓芳.参附注射液对戊巴比妥钠致心衰模型心肌细胞膜ATP酶和相关离子的影响[J].中国实验方剂学杂志,2013,19(7):196-199.
作者姓名:徐菲飞  彭成  王茁伉  谢晓芳
作者单位:成都中医药大学药学院,成都 610075;成都中医药大学药学院,成都 610075;成都中医药大学药学院,成都 610075;成都中医药大学药学院,成都 610075
基金项目:国家"十二五"科技支撑计划(2011BA113B05);国家科技重大专项——重大新药创制专项(2013ZX09201018)
摘    要:目的: 通过探讨参附注射液对新生大鼠心力衰竭心肌细胞Ca2+-ATP酶,Ca2+-Mg2+-ATP酶、Na+-K+-ATP酶活性及细胞内Na+,Mg2+,K+,Ca2+浓度的影响,揭示参附注射液强心作用的机制。 方法: 通过胰蛋白酶消化法和差速贴壁法获得心肌细胞,经0.8%戊巴比妥钠作用5min后,分别给予1.5, 3, 6 mg·L-1(5,10,20 mL·L-1)3个不同浓度的参附注射液,作用1 h,检测心肌细胞Ca2+-ATP酶,Ca2+-Mg2+-ATP酶,Na+-K+-ATP酶的活性和细胞内Na+,Mg2+,K+,Ca2+的浓度。 结果: 参附注射液能增加心衰模型心肌细胞的搏动强度,提高Ca2+-ATP酶和Ca2+-Mg2+-ATP酶的活性,抑制Na+-K+-ATP酶的活性,降低细胞内K+,Ca2+的浓度,升高细胞内Na+,Mg2+的浓度。 结论: 参附注射液对戊巴比妥钠致心衰细胞有明显的保护作用,且作用的发挥与调节心肌细胞Ca2+-ATP酶,Ca2+-Mg2+-ATP酶,Na+-K+-ATP酶的活性和细胞内Na+,Mg2+,K+,Ca2+的浓度有关。

关 键 词:心力衰竭  参附注射液  Ca2+-ATP酶  Na+-K+-ATP酶  Ca2+-Mg2+-ATP酶  心肌细胞
收稿时间:2012/12/11 0:00:00

Effects of the Shenfu Injection on ATPase and Related Ion of Heart Failure Model Myocardial Cell
XU Fei-fei,PENG Cheng,WANG Zhuo-kang and XIE Xiao-fang.Effects of the Shenfu Injection on ATPase and Related Ion of Heart Failure Model Myocardial Cell[J].China Journal of Experimental Traditional Medical Formulae,2013,19(7):196-199.
Authors:XU Fei-fei  PENG Cheng  WANG Zhuo-kang and XIE Xiao-fang
Affiliation:Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China;Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China;Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China;Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China
Abstract:Objective: To study the effects of Shenfu injection on the Ca2+-Mg2+-ATP ase, Ca2+-ATP ase, Na+-K+-ATP and Na+, Mg2+, K+, Ca2+ in the myocardial cell injured by nembutal. Method: The myocardial cell is gotten by trypsin digestion and purified by different velocity of adherence. After injured by 0.8% nembutal, the myocardial cell is administrated with 3 different concentrations of Shenfu Injection. Then mensurate the vitality of the Ca2+-Mg2+-ATP ase, Na+-K+-ATP ase and Ca2+-ATP ase and Na+, Mg2+, K+, Ca2+ in the cell 1 h later. Result: The Shenfu injection can increase the strength of the myocardial cell beating injured by nembutal, and enhance the activity of Ca2+-ATP ase and the Ca2+-Mg2+-ATP ase, inhibit the the activity of Na+-K+-ATP, enzyme increase the content of Na+, Mg2+ and decrease the content of K+, Ca2+ in the myocardial cell. Conclusion: The Shenfu injection can protect the myocardial cell injured by nembutal, and the function is relevent to the effects of Shenfu injection on the Ca2+-Mg2+-ATP ase, Na+-K+-ATP ase, Ca2+-ATP ase and the content of Na+, Mg2+, K+, Ca2+ of myocardial cell.
Keywords:congestive heart failure  Shenfu injection  Ca2+-Mg2+-ATP ase  Ca2+-ATP ase  Na+-K+-ATP ase  Myocardial cell
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号